Ivabradine for heart rate reduction during exercise in healthy adults
Treatments studied
This trial tests a medication called ivabradine that may lower your heart rate during exercise. It is studying healthy adults to see how the medicine affects heart rate while you are active.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19-39 or 60-79 years old.
- You are healthy and exercise regularly (like running, cycling, or sports) at least once a week.
- You do not have any heart or lung conditions, high blood pressure, diabetes, or other chronic illnesses.
- You do not take any daily medications, including for asthma.
- You have not smoked or vaped in the past year.
- You are not pregnant, breastfeeding, and if able to become pregnant you use birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a target heart rate (below 80 beats per minute) is better than a more lenient one for people with persistent or permanent atrial fibrillation. It aims to find the best way to control your heart rate and improve your quality of life.
This trial tests two medicines to lower heart rate before a cardiac CT scan in adults who need the scan. It is for people whose heart rate is naturally a bit fast (over 65 beats per minute) but not too fast (under 100 bpm).
This trial tests if ivabradine, a drug that lowers heart rate, can help patients in cardiogenic shock after a type of heart attack called STEMI. It is for patients with a fast heart rate (at least 100 beats per minute) who cannot take beta-blockers.
This study tests if Ivabradine can safely lower a fast heart rate in people with severe infections (sepsis or septic shock). It may help by reducing strain on the heart without affecting blood pressure.
This study tests whether ivabradine (a heart-rate medicine) can improve blood flow and other vital measurements in adults with sepsis in the ICU. It may help by lowering a fast heart rate when blood pressure is already being supported.
This study compares two medications (atenolol and ivabradine) to see which one better controls a fast heart rate (tachycardia) in people with treatment-resistant schizophrenia who are taking clozapine. The goal is to find a safer way to manage this side effect.
Hear when a new Healthy Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.